Intracranial aneurysm (IA) is a critical cerebrovascular disorder strongly linked to phenotypic switching and apoptosis of vascular smooth muscle cells (VSMCs). This study aimed to investigate the role of circGNAQ in IA development and elucidate its underlying molecular mechanisms.
Results:
Reverse transcription-quantitative polymerase chain reaction and fluorescence in situ hybridization revealed significant upregulation of circGNAQ in IA tissues, predominantly localized within VSMCs. In vitro, circGNAQ knockdown attenuated hydrogen peroxide-induced VSMC phenotypic switching and apoptosis, whereas circGNAQ overexpression aggravated these pathological processes. RNA pull-down and mass spectrometry demonstrated that circGNAQ specifically binds to serine/arginine-rich splicing factor 1 (SRSF1), promoting its ubiquitination and degradation, thereby destabilizing SRSF1. Cotransfection assays confirmed that SRSF1 functions as a downstream mediator of circGNAQ in regulating VSMC phenotypic switching and apoptosis. In vivo, circGNAQ knockdown significantly suppressed IA formation in a murine model by inhibiting VSMC phenotypic switching and apoptosis.
Innovation and Conclusion:
This study identifies circGNAQ as a novel regulator of VSMC phenotypic switching and apoptosis through targeting SRSF1. The findings highlight circGNAQ as a potential therapeutic target for preventing and treating IA. Antioxid. Redox Signal. 44, 24–40.
CalabreseV, ScapagniniG, RavagnaA, et al.Regional distribution of heme oxygenase, HSP70, and glutathione in brain: Relevance for endogenous oxidant/antioxidant balance and stress tolerance. J Neurosci Res, 2002; 68(1):65–75; doi: 10.1002/jnr.10177
3.
ChalouhiN, AliMS, JabbourPM, et al.Biology of intracranial aneurysms: Role of inflammation. J Cereb Blood Flow Metab, 2012; 32(9):1659–1676; doi: 10.1038/jcbfm.2012.84
4.
ChenLL. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat Rev Mol Cell Biol, 2020; 21(8):475–490; doi: 10.1038/s41580-020-0243-y
5.
DasS, KrainerAR. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol Cancer Res, 2014; 12(9):1195–1204; doi: 10.1158/1541-7786.Mcr-14-0131
6.
DingX, WangX, HanL, et al.CircRNA DOCK1 Regulates miR-409-3p/MCL1 axis to modulate proliferation and apoptosis of human brain vascular smooth muscle cells. Front Cell Dev Biol, 2021; 9:655628; doi: 10.3389/fcell.2021.655628
7.
DuJX, LuoYH, ZhangSJ, et al.Splicing factor SRSF1 promotes breast cancer progression via oncogenic splice switching of PTPMT1. J Exp Clin Cancer Res, 2021; 40(1):171; doi: 10.1186/s13046-021-01978-8
FrösenJ, TulamoR, PaetauA, et al.Saccular intracranial aneurysm: Pathology and mechanisms. Acta Neuropathol, 2012; 123(6):773–786; doi: 10.1007/s00401-011-0939-3
11.
GaoS, GaoS, SunZ, et al.MicroRNA-322 inhibition of calcification of arterial smooth muscle cells by regulation of galactosyltransferase 1-associating protein UBE2Q1 and Runx2. Cardiology Plus, 2023; 8(1):27–36; doi: 10.1097/cp9.0000000000000039
12.
HeX, LiX, HanY, et al.CircRNA Chordc1 protects mice from abdominal aortic aneurysm by contributing to the phenotype and growth of vascular smooth muscle cells. Mol Ther Nucleic Acids, 2022; 27:81–98; doi: 10.1016/j.omtn.2021.11.005
13.
HuangA, ZhengH, WuZ, et al.Circular RNA-protein interactions: Functions, mechanisms, and identification. Theranostics, 2020; 10(8):3503–3517; doi: 10.7150/thno.42174
14.
HuangJ, ZhangH, YouL, et al.Coenzyme Q10 inhibits intracranial aneurysm formation and progression in a mouse model. Pediatr Res, 2022; 91(4):839–845; doi: 10.1038/s41390-021-01512-8
15.
JuJ, SongYN, ChenXZ, et al.circRNA is a potential target for cardiovascular diseases treatment. Mol Cell Biochem, 2022; 477(2):417–430; doi: 10.1007/s11010-021-04286-z
16.
KristensenLS, AndersenMS, StagstedLVW, et al.The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet, 2019; 20(11):675–691; doi: 10.1038/s41576-019-0158-7
17.
LiS, ShiY, LiuP, et al.Metformin inhibits intracranial aneurysm formation and progression by regulating vascular smooth muscle cell phenotype switching via the AMPK/ACC pathway. J Neuroinflammation, 2020; 17(1):191; doi: 10.1186/s12974-020-01868-4
18.
LiTX, YangYY, ZongJB, et al.Activated neutrophil membrane-coated tRF-Gly-CCC nanoparticles for the treatment of aortic dissection/aneurysm. J Control Release, 2025a;378:334–349; doi: 10.1016/j.jconrel.2024.12.015
19.
LiX, YangY, WangZ, et al.CircHIPK3 targets DRP1 to mediate hydrogen peroxide-induced necroptosis of vascular smooth muscle cells and atherosclerotic vulnerable plaque formation. J Adv Res, 2025b;69:329–341; doi: 10.1016/j.jare.2024.04.011
20.
LiY, GuoJ, YuH, et al.Valsartan prevented neointimal hyperplasia and inhibited SRSF1 expression and the TLR4-iNOS-ERK-AT1 receptor pathway in the balloon-injured rat aorta. Physiol Res, 2021; 70(4):533–542; doi: 10.33549/physiolres.934579
21.
LiuY, QiH, ZongJ, et al.Oral Piwi-Interacting RNA delivery mediated by green tea-derived exosome-like nanovesicles for the treatment of aortic dissection. Adv Healthc Mater, 2024a;13(30):e2401466; doi: 10.1002/adhm.202401466
22.
LiuY, YangY, LiM, et al.CircTMEM165 facilitates endothelial repair by modulating mitochondrial fission via miR-192/SCP2 in vitro and in vivo. iScience, 2024b;27(4):109502; doi: 10.1016/j.isci.2024.109502
23.
LvY, ZhangW, ZhaoJ, et al.SRSF1 inhibits autophagy through regulating Bcl-x splicing and interacting with PIK3C3 in lung cancer. Signal Transduct Target Ther, 2021; 6(1):108; doi: 10.1038/s41392-021-00495-6
24.
MengS, LiuH, XuJ, et al.PRMT5-Mediated ALKBH5 methylation promotes colorectal cancer immune evasion via increasing CD276 expression. Research (Wash D C), 2025; 8:549; doi: 10.34133/research.0549
25.
NorthoffBH, HerbstA, WenkC, et al.Circular RNAs increase during vascular cell differentiation and are biomarkers for vascular disease. Cardiovasc Res, 2025; 121(3):405–423; doi: 10.1093/cvr/cvaf013
26.
PanT, ShiY, YuG, et al.Intracranial aneurysms and lipid metabolism disorders: From molecular mechanisms to clinical implications. Biomolecules, 2023; 13(11):1652; doi: 10.3390/biom13111652
27.
PazS, RitchieA, MauerC, et al.The RNA binding protein SRSF1 is a master switch of gene expression and regulation in the immune system. Cytokine Growth Factor Rev, 2021; 57:19–26; doi: 10.1016/j.cytogfr.2020.10.008
28.
PengD, LuoL, ZhangX, et al.CircRNA: An emerging star in the progression of glioma. Biomed Pharmacother, 2022; 151:113150; doi: 10.1016/j.biopha.2022.113150
PierotL, GawlitzaM, SoizeS. Unruptured intracranial aneurysms: Management strategy and current endovascular treatment options. Expert Rev Neurother, 2017; 17(10):977–986; doi: 10.1080/14737175.2017.1371593
31.
PontesFGB, da SilvaEM, Baptista-SilvaJC, et al.Treatments for unruptured intracranial aneurysms. Cochrane Database Syst Rev, 2021; 5(5):Cd013312; doi: 10.1002/14651858.CD013312.pub2
32.
ShiY, LiS, SongY, et al.Nrf-2 signaling inhibits intracranial aneurysm formation and progression by modulating vascular smooth muscle cell phenotype and function. J Neuroinflammation, 2019; 16(1):185; doi: 10.1186/s12974-019-1568-3
33.
SongH, YangY, SunY, et al.Circular RNA Cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation. Mol Ther, 2022; 30(2):915–931; doi: 10.1016/j.ymthe.2021.09.017
34.
StarkeRM, ChalouhiN, AliMS, et al.The role of oxidative stress in cerebral aneurysm formation and rupture. Curr Neurovasc Res, 2013; 10(3):247–255; doi: 10.2174/15672026113109990003
35.
SuQ, LvXW, XuYL, et al.Exosomal LINC00174 derived from vascular endothelial cells attenuates myocardial I/R injury via p53-mediated autophagy and apoptosis. Mol Ther Nucleic Acids, 2021; 23:1304–1322; doi: 10.1016/j.omtn.2021.02.005
36.
SunJ, JinT, NiuZ, et al.LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation. Acta Pharm Sin B, 2022; 12(9):3602–3617; doi: 10.1016/j.apsb.2022.04.006
37.
SunderlandK, JiangJ, ZhaoF. Disturbed flow’s impact on cellular changes indicative of vascular aneurysm initiation, expansion, and rupture: A pathological and methodological review. J Cell Physiol, 2022; 237(1):278–300; doi: 10.1002/jcp.30569
38.
TawkRG, HasanTF, D’SouzaCE, et al.Diagnosis and treatment of unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage. Mayo Clin Proc, 2021; 96(7):1970–2000; doi: 10.1016/j.mayocp.2021.01.005
39.
TurjmanAS, TurjmanF, EdelmanER. Role of fluid dynamics and inflammation in intracranial aneurysm formation. Circulation, 2014; 129(3):373–382; doi: 10.1161/circulationaha.113.001444
40.
WangC, YuB, ZhouH, et al.tRF-AspGTC promotes intracranial aneurysm formation by controlling TRIM29-Mediated Galectin-3 Ubiquitination. Research (Wash D C), 2025; 8:574; doi: 10.34133/research.0574
41.
WangL, XuGE, SpanosM, et al.Circular RNAs in cardiovascular diseases: Regulation and therapeutic applications. Research (Wash D C), 2023a;6:38; doi: 10.34133/research.0038
42.
WangY, EmetoTI, LeeJ, et al.Mouse models of intracranial aneurysm. Brain Pathol, 2015; 25(3):237–247; doi: 10.1111/bpa.12175
43.
WangY, SunJ, LiR, et al.Increased aneurysm wall permeability colocalized with low wall shear stress in unruptured saccular intracranial aneurysm. J Neurol, 2022; 269(5):2715–2719; doi: 10.1007/s00415-021-10869-z
44.
WangZ, MaJ, YueH, et al.Vascular smooth muscle cells in intracranial aneurysms. Microvasc Res, 2023b;149:104554; doi: 10.1016/j.mvr.2023.104554
45.
WuWP, ZhouMY, LiuDL, et al.circGNAQ, a circular RNA enriched in vascular endothelium, inhibits endothelial cell senescence and atherosclerosis progression. Mol Ther Nucleic Acids, 2021; 26:374–387; doi: 10.1016/j.omtn.2021.07.020
46.
XieN, ChenM, DaiR, et al.SRSF1 promotes vascular smooth muscle cell proliferation through a Δ133p53/EGR1/KLF5 pathway. Nat Commun, 2017; 8:16016; doi: 10.1038/ncomms16016
47.
YiQ, YueJ, LiuY, et al.Recent advances of exosomal circRNAs in cancer and their potential clinical applications. J Transl Med, 2023; 21(1):516; doi: 10.1186/s12967-023-04348-4
48.
YuF, ZhangY, WangZ, et al.Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3. Theranostics, 2021a;11(11):5404–5417; doi: 10.7150/thno.48389
49.
YuT, LiX, WangC, et al.Lactylation of mitochondrial adenosine triphosphate synthase subunit alpha regulates vascular remodeling and progression of aortic dissection. Research (Wash D C), 2025; 8:799; doi: 10.34133/research.0799
50.
YuT, WangY, FanY, et al.CircRNAs in cancer metabolism: A review. J Hematol Oncol, 2019; 12(1):90; doi: 10.1186/s13045-019-0776-8
51.
YuZ, HuangQ, ZhangQ, et al.CircRNAs open a new era in the study of cardiovascular disease (Review). Int J Mol Med, 2021b;47(1):49–64; doi: 10.3892/ijmm.2020.4792
52.
ZhangZ, SuiR, GeL, et al.CircRNA_0079586 and circRNA_RanGAP1 are involved in the pathogenesis of intracranial aneurysms rupture by regulating the expression of MPO. Sci Rep, 2021; 11(1):19800; doi: 10.1038/s41598-021-99062-w
53.
ZhouD, LiT, TanX, et al.Secreted Protein Acidic and Rich in Cysteine (SPARC) induces apoptosis of human brain vascular smooth muscle cells through regulating HK2 in intracranial aneurysm. Front Mol Neurosci, 2023; 16:1290556; doi: 10.3389/fnmol.2023.1290556
54.
ZhouWY, CaiZR, LiuJ, et al.Circular RNA: Metabolism, functions and interactions with proteins. Mol Cancer, 2020; 19(1):172; doi: 10.1186/s12943-020-01286-3
55.
ZorovDB, JuhaszovaM, SollottSJ. Mitochondrial Reactive Oxygen Species (ROS) and ROS-induced ROS release. Physiol Rev, 2014; 94(3):909–950; doi: 10.1152/physrev.00026.2013
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
